BIOTECanada welcomes the announcement that the Government of Canada has entered into a bilateral agreement with the province of British Columbia which will improve access to drugs for rare diseases,… Read More
VANCOUVER, BC – WEX Pharmaceuticals Inc. (“WEX” or the “Company”), a biotechnology company developing Halneuron® (Tetrodotoxin for Injection) for pain treatment, announced that it has filed a patent application for… Read More
The Research Approvals Processes Project (RAPP) has completed process mapping of the current state for privacy and operational streams of the research approval processes for all health authorities (for more… Read More
RSV vaccination recommended for Quebec adults living in residential and long-term care centres (CHSLD), intermediate resources (RI-SAPA) RSV vaccination recommended for Quebec residents aged 75 and up living in private… Read More
The conversion of this indication from Notice of Compliance (NOC/c) to full approval (NOC) is based on long term outcomes from the GARNET phase I trial, which demonstrated an objective… Read More
